IIPR: AFFO rose 7% sequentially as life science investment and portfolio leasing accelerated

What happened

Q3 AFFO per share rose 7% sequentially to $1.96, helped by rent recoveries and new leasing. Life science commitments expanded to about $545 million, and 874,000 square feet was leased since July.

Confirmed

Global impact / market context

Rising AFFO, which means cash profit adjusted for property accounting items, shows the company is collecting more rent per share. Expanding life science commitments and new square footage leased point to growing rental revenue ahead, which supports the dividend-paying property model.

Analyst inference

This suggests demand for specialized life science space is holding up and the company is finding tenants for its properties. Investors weighing this real estate investment trust, which means a company that owns income-producing property, would focus on leasing pace and rent collection as signs of cash flow durability.

Analyst inference

What to watch

1. Watch whether rent recoveries and new leasing keep lifting AFFO per share beyond the reported $1.96, since these were cited as supports for the quarterly increase. Confirmed
2. Monitor how quickly the approximately $545 million of life science commitments convert into signed leases and rent, because commitments are pledges that may not yet produce cash. Proposed
3. Track leasing of the 874,000 square feet taken since July for follow-on rent revenue and occupancy, since filling space drives the rental income behind profit per share. Analyst inference

Evidence

• Original source link unavailable